Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression

FEBS Letters ◽  
2011 ◽  
Vol 585 (7) ◽  
pp. 1103-1111 ◽  
Author(s):  
Ann Florence B. Victoriano ◽  
Kenichi Imai ◽  
Hiroaki Togami ◽  
Takaharu Ueno ◽  
Kaori Asamitsu ◽  
...  
Keyword(s):  
Gene Expression ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Deacetylase Inhibitor ◽  
Latent Hiv ◽  
Hiv 1

The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression in CD4+ T-cells and monocytes and induces latent HIV-1 expression in vitro

Cytokine ◽  
2009 ◽  
Vol 48 (1-2) ◽  
pp. 61
Author(s):  
Shay Matalon ◽  
Brent E. Palmer ◽  
Marcel F. Nold ◽  
Antonio Furlan ◽  
Gianluca Fossati ◽  
...  
Keyword(s):  
T Cells ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Cd4 T Cells ◽  
Ccr5 Expression ◽  
Deacetylase Inhibitor ◽  
Latent Hiv ◽  
Hiv 1

Chidamide, a histone deacetylase inhibitor-based anticancer drug, effectively reactivates latent HIV-1 provirus

2018 ◽  
Vol 20 (9-10) ◽  
pp. 626-634 ◽  
Author(s):  
Wenqian Yang ◽  
Zhiwu Sun ◽  
Chen Hua ◽  
Qian Wang ◽  
Wei Xu ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Anticancer Drug ◽  
Histone Deacetylase Inhibitor ◽  
Deacetylase Inhibitor ◽  
Latent Hiv ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document